Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for NPDR with DME
NCT02834663Phase 4Completed
- Sponsor
- Wonkwang University Hospital
- Start
- Aug 2016
- Primary completion
- Feb 2019
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of ranibizumab in diabetic macular edema (DME), sponsored by Wonkwang University Hospital. Started Aug 2016; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02834663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02834663.